AU2003257103A1 - Gelatin capsule exhibiting reduced cross-linking - Google Patents

Gelatin capsule exhibiting reduced cross-linking

Info

Publication number: AU2003257103A1
Authority: AU; Australia
Prior art keywords: linking; gelatin capsule; reduced cross; exhibiting reduced; capsule exhibiting
Prior art date: 2002-07-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003257103A

Other languages

English (en)

Other versions

AU2003257103A8 (en

Inventor

Ping Gao

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pharmacia LLC

Original Assignee

Pharmacia LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-31

Filing date

2003-07-31

Publication date

2004-02-16

2003-07-31 Application filed by Pharmacia LLC filed Critical Pharmacia LLC

2004-02-16 Publication of AU2003257103A8 publication Critical patent/AU2003257103A8/xx

2004-02-16 Publication of AU2003257103A1 publication Critical patent/AU2003257103A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Virology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Tropical Medicine & Parasitology (AREA)
Cardiology (AREA)
Oncology (AREA)
Addiction (AREA)
Psychiatry (AREA)
Communicable Diseases (AREA)
Reproductive Health (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Gastroenterology & Hepatology (AREA)
AIDS & HIV (AREA)
Ophthalmology & Optometry (AREA)
Obesity (AREA)

AU2003257103A 2002-07-31 2003-07-31 Gelatin capsule exhibiting reduced cross-linking Abandoned AU2003257103A1 (en)

Applications Claiming Priority (9)

Application Number	Priority Date	Filing Date	Title
US39986202P	2002-07-31	2002-07-31
US39986302P	2002-07-31	2002-07-31
US39977602P	2002-07-31	2002-07-31
US39980802P	2002-07-31	2002-07-31
US60/399,862		2002-07-31
US60/399,776		2002-07-31
US60/399,863		2002-07-31
US60/399,808		2002-07-31
PCT/US2003/024045 WO2004010974A2 (fr)	2002-07-31	2003-07-31	Capsule de gelatine a reticulation reduite

Publications (2)

Publication Number	Publication Date
AU2003257103A8 AU2003257103A8 (en)	2004-02-16
AU2003257103A1 true AU2003257103A1 (en)	2004-02-16

Family

ID=31192378

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
AU2003257102A Abandoned AU2003257102A1 (en)	2002-07-31	2003-07-31	Pharmaceutical dosage form comprising a sulfite compound
AU2003257982A Abandoned AU2003257982A1 (en)	2002-07-31	2003-07-31	Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage
AU2003257981A Abandoned AU2003257981A1 (en)	2002-07-31	2003-07-31	Pellicle-resistant gelatin capsule
AU2003257103A Abandoned AU2003257103A1 (en)	2002-07-31	2003-07-31	Gelatin capsule exhibiting reduced cross-linking

Family Applications Before (3)

Application Number	Title	Priority Date	Filing Date
AU2003257102A Abandoned AU2003257102A1 (en)	2002-07-31	2003-07-31	Pharmaceutical dosage form comprising a sulfite compound
AU2003257982A Abandoned AU2003257982A1 (en)	2002-07-31	2003-07-31	Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage
AU2003257981A Abandoned AU2003257981A1 (en)	2002-07-31	2003-07-31	Pellicle-resistant gelatin capsule

Country Status (7)

Country	Link
EP (4)	EP1526846A2 (fr)
JP (4)	JP2005538102A (fr)
AU (4)	AU2003257102A1 (fr)
BR (4)	BR0313150A (fr)
CA (4)	CA2493980A1 (fr)
MX (4)	MXPA05000862A (fr)
WO (4)	WO2004010972A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003103582A2 (fr)	2002-06-05	2003-12-18	Ivax Corporation	Reduction de la reticulation de gelatine
CN101142198B (zh)	2005-02-17	2012-10-31	辛塔制药公司	用于治疗疾病的异*唑坎布雷它斯丁衍生物
US7485323B2 (en)	2005-05-31	2009-02-03	Gelita Ag	Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions
ATE485033T1 (de) *	2005-07-26	2010-11-15	Nicox Sa	Pharmazeutische formulierung von nitrooxy- derivaten von nsar
JP5503939B2 (ja) *	2009-10-16	2014-05-28	東洋カプセル株式会社	アゼラスチン塩酸塩含有カプセル剤
JP6887456B2 (ja)	2018-07-04	2021-06-16	キャプシュゲル・ベルジウム・エヌ・ヴィ	白色化剤として界面活性剤又は界面活性剤と塩を含有する皮膜形成性組成物
US11364478B2 (en) *	2019-05-22	2022-06-21	Mezzimatic, LLC	Method of manufacturing throwable paintballs and paintballs made therefrom
KR20220077091A (ko) *	2020-12-01	2022-06-08	주식회사 엘지화학	1-(3-시아노-1-아이소프로필-인돌-5-일)피라졸-4-카르복실산을 포함하는 안정한 경구용 제제
CN113230241A (zh) *	2021-06-11	2021-08-10	北京畅盛医药科技有限公司	三羟甲基氨基甲烷盐在治疗心脑血管病的药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5115094B2 (fr) *	1972-11-01	1976-05-14
US4349529A (en) *	1980-04-14	1982-09-14	E. R. Squibb & Sons, Inc.	Diagnostic and therapeutic capsules and method of producing
US4590183A (en) *	1985-04-22	1986-05-20	Sterling Drug Inc.	Gastric cytoprotection with sodium thiosulfate in oral administration of aspirin
FR2617047B1 (fr) *	1987-06-23	1991-05-10	Sanofi Sa	Composition de gelatine resistant au tannage, capsules a base de cette composition et leur application pharmaceutique, notamment au fenofibrate
JP2790659B2 (ja) *	1989-06-30	1998-08-27	帝国臓器製薬株式会社	ゼラチンカプセル剤
KR100338851B1 (ko) *	1994-03-15	2002-10-12	센주 세이야꾸 가부시키가이샤	프라노프로펜의안정화방법및안정한프라노프로펜약제
IT1269583B (it) *	1994-04-26	1997-04-08	Bayer Italia Spa	Preparazioni farmaceutiche a base di una soluzione di ketoprofene in capsule di gelatina molle e metodo per la loro produzione
DK0695544T3 (da) *	1994-08-05	2001-01-02	Shionogi & Co	Hårde gelatinekapsler, der kan modstå denaturering, og fremgangsmåde til fremstilling heraf
US5620704A (en) *	1994-11-07	1997-04-15	Warner-Lambert Company	Process for stabilizing gelatin products
US7115565B2 (en) *	2001-01-18	2006-10-03	Pharmacia & Upjohn Company	Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability

2003
- 2003-07-31 BR BR0313150-5A patent/BR0313150A/pt not_active IP Right Cessation
- 2003-07-31 EP EP03772161A patent/EP1526846A2/fr not_active Withdrawn
- 2003-07-31 JP JP2004524263A patent/JP2005538102A/ja not_active Abandoned
- 2003-07-31 EP EP03772160A patent/EP1526845A2/fr not_active Withdrawn
- 2003-07-31 MX MXPA05000862A patent/MXPA05000862A/es not_active Application Discontinuation
- 2003-07-31 JP JP2004524262A patent/JP2005538994A/ja not_active Withdrawn
- 2003-07-31 MX MXPA05001272A patent/MXPA05001272A/es unknown
- 2003-07-31 CA CA002493980A patent/CA2493980A1/fr not_active Abandoned
- 2003-07-31 MX MXPA05001167A patent/MXPA05001167A/es unknown
- 2003-07-31 JP JP2004534259A patent/JP2006500389A/ja not_active Withdrawn
- 2003-07-31 AU AU2003257102A patent/AU2003257102A1/en not_active Abandoned
- 2003-07-31 WO PCT/US2003/024042 patent/WO2004010972A2/fr not_active Ceased
- 2003-07-31 CA CA002493974A patent/CA2493974A1/fr not_active Abandoned
- 2003-07-31 JP JP2004524261A patent/JP2005538993A/ja not_active Withdrawn
- 2003-07-31 CA CA002494069A patent/CA2494069A1/fr not_active Abandoned
- 2003-07-31 WO PCT/US2003/024045 patent/WO2004010974A2/fr not_active Ceased
- 2003-07-31 EP EP03794452A patent/EP1526847A2/fr not_active Withdrawn
- 2003-07-31 WO PCT/US2003/024043 patent/WO2004010973A2/fr not_active Ceased
- 2003-07-31 AU AU2003257982A patent/AU2003257982A1/en not_active Abandoned
- 2003-07-31 WO PCT/US2003/024044 patent/WO2004022032A2/fr not_active Ceased
- 2003-07-31 BR BR0313064-9A patent/BR0313064A/pt not_active IP Right Cessation
- 2003-07-31 MX MXPA05001166A patent/MXPA05001166A/es unknown
- 2003-07-31 BR BR0313149-1A patent/BR0313149A/pt not_active IP Right Cessation
- 2003-07-31 BR BR0312875-0A patent/BR0312875A/pt not_active IP Right Cessation
- 2003-07-31 CA CA002494358A patent/CA2494358A1/fr not_active Abandoned
- 2003-07-31 AU AU2003257981A patent/AU2003257981A1/en not_active Abandoned
- 2003-07-31 EP EP03772159A patent/EP1526844A2/fr not_active Withdrawn
- 2003-07-31 AU AU2003257103A patent/AU2003257103A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU2003257981A8 (en)	2004-02-16
JP2005538993A (ja)	2005-12-22
WO2004010972A3 (fr)	2004-07-29
WO2004022032A3 (fr)	2004-08-12
AU2003257102A8 (en)	2004-03-29
AU2003257982A8 (en)	2004-02-16
CA2494358A1 (fr)	2004-02-05
AU2003257102A1 (en)	2004-03-29
JP2006500389A (ja)	2006-01-05
AU2003257981A1 (en)	2004-02-16
JP2005538994A (ja)	2005-12-22
BR0313064A (pt)	2005-06-28
BR0313150A (pt)	2005-06-28
WO2004022032A2 (fr)	2004-03-18
MXPA05001166A (es)	2005-05-16
EP1526844A2 (fr)	2005-05-04
AU2003257103A8 (en)	2004-02-16
WO2004010972A2 (fr)	2004-02-05
EP1526846A2 (fr)	2005-05-04
EP1526845A2 (fr)	2005-05-04
WO2004010973A3 (fr)	2004-08-05
JP2005538102A (ja)	2005-12-15
MXPA05001272A (es)	2005-04-28
WO2004010973A2 (fr)	2004-02-05
BR0312875A (pt)	2005-06-28
CA2494069A1 (fr)	2004-02-05
WO2004010974A2 (fr)	2004-02-05
WO2004010974A3 (fr)	2004-08-05
CA2493980A1 (fr)	2004-02-05
BR0313149A (pt)	2005-06-28
EP1526847A2 (fr)	2005-05-04
MXPA05001167A (es)	2005-05-16
AU2003257982A1 (en)	2004-02-16
MXPA05000862A (es)	2005-04-19
CA2493974A1 (fr)	2004-03-18

Publication	Publication Date	Title
EP1549299A4 (fr)	2010-12-15	Reduction de la reticulation de gelatine
AU2003221551A1 (en)	2003-10-27	Self cross-linking polyurethane-dispersions
AU3711200A (en)	2000-09-21	Gum acacia substituted soft gelatin capsules
AU2003303946A1 (en)	2004-11-23	Tandem warhead
AU2003292155A1 (en)	2004-06-18	Radiation-sensitive elements
AU2003275620A1 (en)	2004-05-13	Capsule type hardener and composition
AU2003255278A1 (en)	2004-03-03	Thick radiation sensitive devices
AU2003242434A1 (en)	2003-12-12	Releasing film
AU2003265509A1 (en)	2004-03-03	Neurostimulator
AU2003257550A1 (en)	2004-03-11	Soft capsule preparation
AU2003283276A1 (en)	2004-05-04	Silicone resins
AU2003275546A1 (en)	2004-05-04	Heat-schrinkable film
AU2003227234A1 (en)	2003-10-08	Cassette
AU2003231439A1 (en)	2003-11-11	Photostabilized soft capsule
EP1336399A3 (fr)	2004-04-28	Film tridimensionnel perforé
AU2003212368A1 (en)	2003-10-08	Printable film
AU2003237201A1 (en)	2003-12-12	Talking e-book
AU2003289075A1 (en)	2004-07-09	Jack-in-the-box
AU2003227946A1 (en)	2003-12-02	Alum pellets
AU2003257103A1 (en)	2004-02-16	Gelatin capsule exhibiting reduced cross-linking
AU2003227233A1 (en)	2003-10-08	Cassette
AU2003230400A1 (en)	2003-12-12	Combined memory
AU2003234813A1 (en)	2003-12-02	Oriented syndiotactic polystyrene-base film
AU2003230655A1 (en)	2003-09-29	Coated pelletized shortening
AU2003211315A1 (en)	2003-10-08	Cross-linked gelatin

Legal Events

Date	Code	Title	Description
2005-05-19	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase